Achievement of Response with Fremanezumab in the Treatment of Chronic Migraine

被引：0
作者：
Winner, Paul K. [1 ]
Bigal, Marcelo E. [2 ]
Aycardi, Ernesto [2 ]
Yeung, Paul P. [2 ]
Blankenbiller, Tricia [2 ]
Grozinski-Wolff, Melissa [2 ]
Yang, Ronghua [2 ]
Ma, Yuju [2 ]
机构：
[1] Palm Beach Headache Ctr, W Palm Beach, FL USA
[2] Teva Pharmaceut, Frazer, PA USA
来源：
NEUROLOGY | 2018年 / 90卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P4.113
引用
收藏
页数：2
相关论文
共 50 条
  • [11] Reversion of Patients With Chronic Migraine to an Episodic Migraine Classification With Fremanezumab Treatment
    Cohen, Joshua M.
    Bibeau, Kristen
    Galic, Maja
    Seminerio, Michael J.
    Campos, Verena Ramirez
    Singh, Rashmi B. Halker
    Ailani, Jessica
    NEUROLOGY, 2018, 90
  • [12] Reversion of patients with chronic migraine to an episodic migraine classification with fremanezumab treatment
    Cohen, Joshua M.
    Bibeau, Kristen
    Galic, Maja
    Seminerio, Michael J.
    Ramirez Campos, Verena
    Singh, Rashmi B. Halker
    Ailani, Jessica
    JOURNAL OF HEADACHE AND PAIN, 2018, 19
  • [13] Early Onset of Efficacy With Fremanezumab for the Preventive Treatment of Chronic Migraine
    Winner, Paul K.
    Spierings, Egilius L. H.
    Yeung, Paul P.
    Aycardi, Ernesto
    Blankenbiller, Tricia
    Grozinski-Wolff, Melissa
    Yang, Ronghua
    Ma, Yuju
    HEADACHE, 2019, 59 (10): : 1743 - 1752
  • [14] Fremanezumab for the preventive treatment of migraine
    Silberstein, Stephen D.
    Cohen, Joshua M.
    Yeung, Paul P.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2019, 19 (08) : 763 - 771
  • [15] Fremanezumab for the prevention of chronic and episodic migraine
    Lionetto, L.
    Cipolla, F.
    Guglielmetti, M.
    Martelletti, P.
    DRUGS OF TODAY, 2019, 55 (04) : 265 - 276
  • [16] Efficacy and tolerability of fremanezumab for migraine preventive treatment in Korean patients with chronic or episodic migraine
    Kim, Byung-Kun
    Cohen, Joshua
    Kim, Sukyung
    Chang, Daeho
    Ning, Xiaoping
    Lengil, Tamar
    Janka, Lindsay
    Barash, Steve
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429 : 214 - 214
  • [17] Reductions in Migraine Frequency with Fremanezumab Treatment by Baseline Migraine Frequency Category in Patients with Chronic and Episodic Migraine
    Nahas, Stephanie J.
    Ning, Xiaoping
    Cohen, Joshua M.
    Barash, Steve
    Campos, Verena Ramirez
    Carr, Karen
    Silberstein, Stephen D.
    ANNALS OF NEUROLOGY, 2021, 90 : S133 - S134
  • [18] REDUCTION IN THE SEVERITY OF HEADACHE IN PATIENTS WITH CHRONIC AND EPISODIC MIGRAINE WITH FREMANEZUMAB TREATMENT
    Ashina, M.
    Cohen, J. M.
    Gandhi, S. K.
    Yang, R.
    CEPHALALGIA, 2018, 38 : 62 - 63
  • [19] Reduction in the Severity of Headache in Patients With Chronic and Episodic Migraine With Fremanezumab Treatment
    Ashina, Messoud
    Cohen, Joshua
    Gandhi, Sanjay
    Yang, Ronghua
    NEUROLOGY, 2019, 92 (15)
  • [20] Fremanezumab for the preventive treatment of migraine in adults
    Lionetto, Luana
    Curto, Martina
    Cisale, Giusy Ylenia
    Capi, Matilde
    Cipolla, Fabiola
    Guglielmetti, Martina
    Martelletti, Paolo
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2019, 12 (08) : 741 - 748
12345